Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010

Gastroenterology

Volumn 143, Issue 2, 2012, Pages 382-389

  Herrinton, Lisa J ^a   Liu, Liyan ^a   Levin, Theodore R ^b   Allison, James E ^a,c   Lewis, James D ^d   Velayos, Fernando ^a,c  

^a DIVISION OF RESEARCH   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cancer Risk; Colon Cancer; Epidemiology; SIRR

Indexed keywords

IMMUNOMODULATING AGENT; TUMOR NECROSIS FACTOR ANTIBODY;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; COLON; COLONOSCOPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; CROHN DISEASE; DISEASE ASSOCIATION; HEALTH CARE DELIVERY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 84864270977     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.04.054     Document Type: Article

References (35)

1. A. Ekbom, C. Helmick, M. Zack Ulcerative colitis and colorectal cancer A population-based study N Engl J Med 323 1990 1228 1233 (Pubitemid 20366527)
2. A. Ekbom, C. Helmick, M. Zack Increased risk of large-bowel cancer in Crohn's disease with colonic involvement Lancet 336 1990 357 359 (Pubitemid 20264156)
3. A. Ekbom, C.G. Helmick, M. Zack Survival and causes of death in patients with inflammatory bowel disease: a population-based study Gastroenterology 103 1992 954 960
4. N.J. Samadder, B. Mukherjee, S.C. Huang Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use Cancer 117 2011 1640 1648
5. P.G. Persson, P. Karlen, O. Bernell Crohn's disease and cancer: a population-based cohort study Gastroenterology 107 1994 1675 1679 (Pubitemid 24357620)
6. M. Mussell, U. Bocker, N. Nagel Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease Eur J Gastroenterol Hepatol 16 2004 1273 1280 (Pubitemid 39627525)
7. M.D. Rutter, B.P. Saunders, K.H. Wilkinson Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk Gut 53 2004 1813 1816 (Pubitemid 39556902)
8. R.B. Gupta, N. Harpaz, S. Itzkowitz Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study Gastroenterology 133 2007 1099 1105 (Pubitemid 47494461)
9. F.S. Velayos, E.V. Loftus Jr, T. Jess Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study Gastroenterology 130 2006 1941 1949 (Pubitemid 43816957)
10. F.A. Farraye, R.D. Odze, J. Eaden AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease Gastroenterology 138 2010 738 745
11. L.J. Herrinton, L. Liu, B. Fireman Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005 Gastroenterology 137 2009 502 511
12. M. Rutter, B. Saunders, K. Wilkinson Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis Gastroenterology 126 2004 451 459 (Pubitemid 38182302)
13. C.N. Bernstein, J.F. Blanchard, E. Kliewer Cancer risk in patients with inflammatory bowel disease: a population-based study Cancer 91 2001 854 862 (Pubitemid 32173312)
14. P. Karlen, R. Lofberg, O. Brostrom Increased risk of cancer in ulcerative colitis: a population-based cohort study Am J Gastroenterol 94 1999 1047 1052 (Pubitemid 29173626)
15. T. Jess, E.V. Loftus Jr, F.S. Velayos Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota Gastroenterology 130 2006 1039 1046
16. K.V. Winther, T. Jess, E. Langholz Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County Gastroenterology 125 2003 1576 1582 (Pubitemid 37500420)
17. K.V. Winther, T. Jess, E. Langholz Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County Clin Gastroenterol Hepatol 2 2004 1088 1095 (Pubitemid 40037640)
18. S. Soderlund, L. Brandt, A. Lapidus Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease Gastroenterology 136 2009 1561 1567 quiz, 818-819
19. N. Gordon How does the adult Kaiser Permanente membership in Northern California compare with the larger community? June 2006 Kaiser Permanente Division of Research Oakland, CA http://www.dor.kaiser.org/dor/mhsnet/public/ kpnc-community.htm Accessed August 5, 2011
20. L.J. Herrinton, L. Liu, J.D. Lewis Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002 Am J Gastroenterol 103 2008 1998 2006
21. Howlader N, Noone AM, Krapcho M, et al, eds. SEER cancer statistics review, 1975-2008, National Cancer Institute. Bethesda, MD http://seer.cancer. gov/csr/1975-2008/ Based on November 2010 SEER data submission, posted to the SEER web site, 2011. Accessed June 6, 2012
22. A. Agresti Exact inference for categorical data: recent advances and continuing controversies Stat Med 20 2001 2709 2722 (Pubitemid 32834378)
23. T.R. Levin, L. Jamieson, D.A. Burley Organized colorectal cancer screening in integrated health care systems Epidemiol Rev 33 2011 101 110
24. G. Hoff, T. Grotmol, E. Skovlund Norwegian Colorectal Cancer Prevention Study Group Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial BMJ 338 2009 b1846
25. F.S. Velayos, L. Liu, J.D. Lewis Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system Gastroenterology 139 2010 1511 1518
26. J.V. Selby, G.D. Friedman, C.P. Quesenberry Jr A case-control study of screening sigmoidoscopy and mortality from colorectal cancer N Engl J Med 326 1992 653 657
27. L.J. Herrinton, J.V. Selby, G.D. Friedman A case-control study of digital-rectal screening in relation to mortality from cancer of the distal rectum Am J Epidemiol 142 1995 961 964
28. M.A. Peppercorn Advances in drug therapy for inflammatory bowel disease Ann Intern Med 112 1990 50 60 (Pubitemid 20026368)
29. D. Pinczowski, A. Ekbom, J. Baron Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study Gastroenterology 107 1994 117 120 (Pubitemid 24195353)
30. G.A. Moody, V. Jayanthi, C.S. Probert Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire Eur J Gastroenterol Hepatol 8 1996 1179 1183 (Pubitemid 26413548)
31. L.J. Herrinton, L. Liu, B. Fireman Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005 Gastroenterology 137 2009 502 511
32. M.D. Rutter, B.P. Saunders, K.H. Wilkinson Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis Gastroenterology 130 2006 1030 1038
33. T. Jess, M. Gamborg, P. Munkholm Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies Am J Gastroenterol 102 2007 609 617 (Pubitemid 46328133)
34. D. Duricova, N. Pedersen, M. Elkjaer Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies Inflamm Bowel Dis 16 2010 347 353
35. S.M. Hutfless, X. Weng, L. Liu Mortality by medication use among patients with inflammatory bowel disease, 1996-2003 Gastroenterology 133 2007 1779 1786 (Pubitemid 350180814)